Oculomotor nerve palsy associated with vincristine treatment.
Soysal
T
T
Department of Medicine, Cerrahpaşa Medical School, University of Istanbul, Turkey.
Ferhanoğlu
B
B
Bilir
M
M
Akman
N
N
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D015840:Oculomotor Nerve Diseases / Q000139:chemically induced* / Q000175:diagnosis; D011241:Prednisone / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects*
D001761:Bleomycin; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D002955:Leucovorin; D011241:Prednisone; D008727:Methotrexate